Hot Flashes and Night Sweats – Market outlook, Epidemiology, Competitive Landscape and Market Forecast Report – 2020 To 2030


 Hot Flashes and Night Sweats are significant symptoms that occur in most women across the globe. A woman with Vasomotor Symptoms experiences much heat accompanied by sweating and flushing, especially around the head, neck, chest, and upper back region. These are the menopausal symptoms for which women seek treatment most often during menopause. VMS results from temperature dysfunction that occurs due to changes in gonadal hormones. 60-80% of women experience VMS during the menopausal transition, with prevalence rates varying by racial/ethnic group. One of the well-known symptoms of menopause is the occurrence of hot flashes, which occur in >75% of menopausal women. Hot flashes are often described as episodic sensations of heat, intense sweating, and flushing affecting the face and chest, often accompanied by palpitations and anxiety. Each episode lasts 3–10 minutes, and attacks can recur with varying frequency. Some women encounter hot flashes hourly or daily, whereas, for others, they may occur occasionally. The age at onset of hot flashes is hypothesized to be involving pathology of the thermoregulatory nucleus that is crucial in controlling the homeostatic condition and, therefore, the core body temperature. The thermoregulatory nucleus maintains the core temperature within the intervals of physiological needs, termed a thermoregulatory zone.

The prevalence of Hot Flashes and Night Sweats varies from 14,560 to 16,500 per 100,000 population in the USA

 

The competitive landscape of Hot Flashes and Night Sweats includes country-specific approved and pipeline therapies. Any asset/product-specific designation or review and Accelerated Approval are tracked and supplemented with analyst commentary.

KOLs insights of Hot Flashes and Night Sweats across 8 MM market from the center of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Hot Flashes and Night Sweats Market Forecast: Patient Based Forecast Model (MS. Excel Based Automated Dashboard) which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Read more: Hot Flashes and Night Sweats – Market outlook, Epidemiology, Market Forecast, and Competitive Landscape Report – 2020 To 2030

S. No    Asset               Company                                 Stage

1          FP-101 Fervent Pharmaceuticals           Phase 2

2          Fezolinetant      Astellas Pharma Inc      Phase 3

3          Erenumab         Amgen  Phase 1

4          Estetrol Donesta Bioscience       Phase 2

5          Gabapentin       Depomed          Phase 3

6          RAD1901          Radius Pharmaceuticals, Inc.     Phase 2

7          MT-8554           Mitsubishi Tanabe Pharma Development America, Inc.       Phase 2

8          G-CSF  MenoGeniX, Inc.           Phase 1

9          Elinzanetant (BAY3427080)       Bayer   Phase 1

10        BRN01  BOIRON           Phase 3

Continued

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Metabolic Syndrome – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Metabolic syndrome refers to a clustering of multiple disorders that collectively increase an individual's susceptibility to atherosclerotic cardiovascular disease, insulin resistance, diabetes mellitus, as well as vascular and neurological complications such as cerebrovascular accidents. The underlying causes of metabolic syndrome typically include excess weight, obesity, a sedentary lifestyle, and genetic predisposition. This syndrome exerts detrimental effects on various body systems. Insulin resistance, a key component of metabolic syndrome, leads to microvascular damage, increasing the risk of endothelial dysfunction, vascular resistance, hypertension, and inflammation of vessel walls. Bariatric surgery is recognized as the most effective standalone therapy for metabolic syndrome. However, patients undergoing this procedure require long-term follow-up to mitigate potential surgical, nutritional, and psychiatric complications. Thelansis’s “Metabolic Syndrome Market Outl...
Read more

Type 1 Diabetes Mellitus (T1D) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
  Type 1 Diabetes Mellitus (T1D) is characterized as an autoimmune disorder resulting in the autoimmune destruction of insulin-producing pancreatic beta cells. This condition necessitates life-long insulin replacement, administered through multiple daily insulin injections, insulin pump therapy, or an automated insulin delivery system. The absence of insulin can lead to the development of Diabetic Ketoacidosis (DKA), a life-threatening condition. The most common symptoms associated with this disease are polyuria and polydipsia. Effective management of T1D involves: Multiple daily insulin injections Insulin pump therapy An automated insulin delivery system in conjunction with glucose monitoring Continuous Glucose Monitoring (CGM) is the preferred method. However, all individuals with T1D should be capable of performing Blood Glucose Monitoring (BGM) via capillary blood if CGM is not available. Acute complications of diabetes primarily include hypo...
Read more